Summary

Peptide Therapeutics Market – Scope of Report
TMR’s report on the global peptide therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global peptide therapeutics market for the period 2019–2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peptide therapeutics market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the peptide therapeutics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peptide therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peptide therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peptide therapeutics market.

The report delves into the competitive landscape of the global peptide therapeutics market. Key players operating in the global peptide therapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peptide therapeutics market profiled in this report.

Key Questions Answered in global peptide therapeutics Market Report
• What is the sales/revenue generated by peptide therapeutics across all regions during the forecast period?
• What are the opportunities in the global peptide therapeutics market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Peptide Therapeutics Market – Research Objectives and Research Approach
The comprehensive report on the global peptide therapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global peptide therapeutics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peptide therapeutics market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Peptide Therapeutics Market
4. Market Overview
    4.1. Introduction
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Peptide Therapeutics Market Analysis and Forecasts, 2020-2035
5. Key Insights
    5.1. FDA-approved Peptide Therapeutics in 2024
    5.2. Peptide Drugs Approved Since 2000, with their Targets and Indications
    5.3. White Space Analysis
    5.4. Porter's Analysis
    5.5. Pipeline Analysis
    5.6. Peptide Drugs Chemical Structure Trend Analysis
    5.7. Separation Media Used for Peptide Drugs
    5.8. Unmet Needs of the Industry
6. Global Peptide Therapeutics Market Analysis and Forecasts, By Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Product Type, 2020-2035
        6.3.1. Innovative
        6.3.2. Generic
    6.4. Market Attractiveness By Product Type
7. Global Peptide Therapeutics Market Analysis and Forecasts, By Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Application, 2020-2035
        7.3.1. Metabolic
        7.3.2. Oncology
        7.3.3. Gastrointestinal
        7.3.4. Cardiovascular
        7.3.5. Neurological
        7.3.6. Others
    7.4. Market Attractiveness By Application
8. Global Peptide Therapeutics Market Analysis and Forecasts, By Route of Administration
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By Route of Administration, 2020-2035
        8.3.1. Parenteral
        8.3.2. Oral
        8.3.3. Others
    8.4. Market Attractiveness By Route of Administration
9. Global Peptide Therapeutics Market Analysis and Forecasts, By Types of Peptide
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast By Types of Peptide, 2020-2035
        9.3.1. Native Peptides
        9.3.2. Analog Peptides
        9.3.3. Heterologous Peptides
    9.4. Market Attractiveness By Types of Peptide
10. Global Peptide Therapeutics Market Analysis and Forecasts, By Technology
    10.1. Introduction & Definition
    10.2. Key Findings / Developments
    10.3. Market Value Forecast By Technology, 2020-2035
        10.3.1. Liquid Phase
        10.3.2. Solid Phase
        10.3.3. Hybrid
    10.4. Market Attractiveness By Technology
11. Global Peptide Therapeutics Market Analysis and Forecasts, By Manufacturing Type
    11.1. Introduction & Definition
    11.2. Key Findings / Developments
    11.3. Market Value Forecast By Manufacturing Type, 2020-2035
        11.3.1. In-house
        11.3.2. CMO
    11.4. Market Attractiveness By Manufacturing Type
12. Global Peptide Therapeutics Market Analysis and Forecasts, By Region
    12.1. Key Findings
    12.2. Market Value Forecast By Region
        12.2.1. North America
        12.2.2. Europe
        12.2.3. Asia Pacific
        12.2.4. Latin America
        12.2.5. Middle East & Africa
    12.3. Market Attractiveness By Region
13. North America Peptide Therapeutics Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Product Type, 2020-2035
        13.2.1. Innovative
        13.2.2. Generic
    13.3. Market Value Forecast By Application, 2020-2035
        13.3.1. Metabolic
        13.3.2. Oncology
        13.3.3. Gastrointestinal
        13.3.4. Cardiovascular
        13.3.5. Neurological
        13.3.6. Others
    13.4. Market Value Forecast By Route of Administration, 2020-2035
        13.4.1. Parenteral
        13.4.2. Oral
        13.4.3. Others
    13.5. Market Value Forecast By Types of Peptide, 2020-2035
        13.5.1. Native Peptides
        13.5.2. Analog Peptides
        13.5.3. Heterologous Peptides
    13.6. Market Value Forecast By Technology, 2020-2035
        13.6.1. Liquid Phase
        13.6.2. Solid Phase
        13.6.3. Hybrid
    13.7. Market Value Forecast By Manufacturing Type, 2020-2035
        13.7.1. In-house
        13.7.2. CMO
    13.8. Market Value Forecast By Country, 2020-2035
        13.8.1. U.S.
        13.8.2. Canada
    13.9. Market Attractiveness Analysis
        13.9.1. By Product Type
        13.9.2. By Application
        13.9.3. By Route of Administration
        13.9.4. By Types of Peptide
        13.9.5. By Technology
        13.9.6. By Manufacturing Type
        13.9.7. By Country
14. Europe Peptide Therapeutics Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Product Type, 2020-2035
        14.2.1. Innovative
        14.2.2. Generic
    14.3. Market Value Forecast By Application, 2020-2035
        14.3.1. Metabolic
        14.3.2. Oncology
        14.3.3. Gastrointestinal
        14.3.4. Cardiovascular
        14.3.5. Neurological
        14.3.6. Others
    14.4. Market Value Forecast By Route of Administration, 2020-2035
        14.4.1. Parenteral
        14.4.2. Oral
        14.4.3. Others
    14.5. Market Value Forecast By Types of Peptide, 2020-2035
        14.5.1. Native Peptides
        14.5.2. Analog Peptides
        14.5.3. Heterologous Peptides
    14.6. Market Value Forecast By Technology, 2020-2035
        14.6.1. Liquid Phase
        14.6.2. Solid Phase
        14.6.3. Hybrid
    14.7. Market Value Forecast By Manufacturing Type, 2020-2035
        14.7.1. In-house
        14.7.2. CMO
    14.8. Market Value Forecast By Country/Sub-region, 2020-2035
        14.8.1. Germany
        14.8.2. U.K.
        14.8.3. France
        14.8.4. Spain
        14.8.5. Italy
        14.8.6. Rest of Europe
    14.9. Market Attractiveness Analysis
        14.9.1. By Product Type
        14.9.2. By Application
        14.9.3. By Route of Administration
        14.9.4. By Types of Peptide
        14.9.5. By Technology
        14.9.6. By Manufacturing Type
        14.9.7. By Country/Sub-region

ページTOPに戻る

List of Tables/Graphs

List of Figures
Figure 01: Global Peptide Therapeutics Market Size, by Application, 2024
Figure 02: Peptide Therapeutics Market share (%), by Application, 2024
Figure 03: Peptide Therapeutics Market Size, by Route of Administration, 2024
Figure 04: Peptide Therapeutics Market share (%), by Route of Administration, 2024
Figure 05: Peptide Therapeutics Market Size, by Product Type, 2024
Figure 06: Peptide Therapeutics Market share (%), by Product Type, 2024
Figure 07: Peptide Therapeutics Market Size, by Types of Peptide, 2024
Figure 08: Peptide Therapeutics Market share (%), by Types of Peptide, 2024
Figure 09: Peptide Therapeutics Market Size, by Technology, 2024
Figure 10: Peptide Therapeutics Market share (%), by Technology, 2024
Figure 11: Peptide Therapeutics Market Size, by Manufacturing Type, 2024
Figure 12: Peptide Therapeutics Market share (%), by Manufacturing Type, 2024
Figure 13: Global Peptide Therapeutics Market, By Region (2024 and 2035)
Figure 14: Global Peptide Therapeutics Market Value (US$ Mn) Forecast, 2020-2035
Figure 16: Global Peptide Therapeutics Market Value Share Analysis, by Product Type, 2024
Figure 15: Global Peptide Therapeutics Market Value Share Analysis, by Product Type, 2024 and 2035
Figure 17: Global Peptide Therapeutics Market Value Share Analysis, by Product Type, 2035
Figure 18: Global Peptide Therapeutics Market Attractiveness Analysis, by Product Type, 2025-2035
Figure 19: Global Peptide Therapeutics Market Value (US$ Mn), by Innovative, 2020-2035
Figure 20: Global Peptide Therapeutics Market Value Share Analysis, by Innovative, 2024 and 2035
Figure 21: Global Peptide Therapeutics Market Value (US$ Mn), by Generic, 2020-2035
Figure 22: Global Peptide Therapeutics Market Value Share Analysis, by Generic, 2024 and 2035
Figure 23: Global Peptide Therapeutics Market Value Share Analysis, by Application, 2024 and 2035
Figure 24: Global Peptide Therapeutics Market Value Share Analysis, by Application, 2024
Figure 25: Global Peptide Therapeutics Market Value Share Analysis, by Application, 2035
Figure 26: Global Peptide Therapeutics Market Attractiveness Analysis, by Application, 2025-2035
Figure 27: Global Peptide Therapeutics Market Value (US$ Mn), by Metabolic, 2020-2035
Figure 28: Global Peptide Therapeutics Market Value Share Analysis, by Metabolic, 2024 and 2035
Figure 29: Global Peptide Therapeutics Market Value (US$ Mn), by Oncology, 2020-2035
Figure 30: Global Peptide Therapeutics Market Value Share Analysis, by Oncology, 2024 and 2035
Figure 31: Global Peptide Therapeutics Market Value (US$ Mn), by Gastrointestinal, 2020-2035
Figure 32: Global Peptide Therapeutics Market Value Share Analysis, by Gastrointestinal, 2024 and 2035
Figure 33: Global Peptide Therapeutics Market Value (US$ Mn), by Cardiovascular, 2020-2035
Figure 34: Global Peptide Therapeutics Market Value Share Analysis, by Cardiovascular, 2024 and 2035
Figure 35: Global Peptide Therapeutics Market Value (US$ Mn), by Neurological, 2020-2035
Figure 36: Global Peptide Therapeutics Market Value Share Analysis, by Neurological, 2024 and 2035
Figure 37: Global Peptide Therapeutics Market Value (US$ Mn), by Others, 2020-2035
Figure 38: Global Peptide Therapeutics Market Value Share Analysis, by Others, 2024 and 2035
Figure 39: Global Peptide Therapeutics Market Value Share Analysis, by Route of Administration Type, 2024 and 2035
Figure 40: Global Peptide Therapeutics Market Value Share Analysis, by Route of Administration Type, 2024
Figure 41: Global Peptide Therapeutics Market Value Share Analysis, by Route of Administration Type, 2035
Figure 42: Global Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration Type, 2025-2035
Figure 43: Global Peptide Therapeutics Market Value (US$ Mn), by Parenteral, 2020-2035
Figure 44: Global Peptide Therapeutics Market Value Share Analysis, by Parenteral, 2024 and 2035
Figure 45: Global Peptide Therapeutics Market Value (US$ Mn), by Oral, 2020-2035
Figure 46: Global Peptide Therapeutics Market Value Share Analysis, by Oral, 2024 and 2035
Figure 47: Global Peptide Therapeutics Market Value (US$ Mn), by Others, 2020-2035
Figure 48: Global Peptide Therapeutics Market Value Share Analysis, by Others, 2024 and 2035
Figure 49: Global Peptide Therapeutics Market Value Share Analysis, by Types of Peptide Type, 2024 and 2035
Figure 50: Global Peptide Therapeutics Market Value Share Analysis, by Types of Peptide Type, 2024
Figure 51: Global Peptide Therapeutics Market Value Share Analysis, by Types of Peptide Type, 2035
Figure 52: Global Peptide Therapeutics Market Attractiveness Analysis, by Types of Peptide Type, 2025-2035
Figure 53: Global Peptide Therapeutics Market Value (US$ Mn), by Native Peptides, 2020-2035
Figure 54: Global Peptide Therapeutics Market Value Share Analysis, by Native Peptides, 2024 and 2035
Figure 55: Global Peptide Therapeutics Market Value (US$ Mn), by Analog Peptides, 2020-2035
Figure 56: Global Peptide Therapeutics Market Value Share Analysis, by Analog Peptides, 2024 and 2035
Figure 57: Global Peptide Therapeutics Market Value (US$ Mn), by Heterologous Peptides, 2020-2035
Figure 58: Global Peptide Therapeutics Market Value Share Analysis, by Heterologous Peptides, 2024 and 2035
Figure 59: Global Peptide Therapeutics Market Value Share Analysis, by Technology Type, 2024 and 2035
Figure 60: Global Peptide Therapeutics Market Value Share Analysis, by Technology Type, 2024
Figure 61: Global Peptide Therapeutics Market Value Share Analysis, by Technology Type, 2035
Figure 62: Global Peptide Therapeutics Market Attractiveness Analysis, by Technology Type, 2025-2035
Figure 63: Global Peptide Therapeutics Market Value (US$ Mn), by Liquid Phase, 2020-2035
Figure 64: Global Peptide Therapeutics Market Value Share Analysis, by Liquid Phase, 2024 and 2035
Figure 65: Global Peptide Therapeutics Market Value (US$ Mn), by Solid Phase, 2020-2035
Figure 66: Global Peptide Therapeutics Market Value Share Analysis, by Solid Phase, 2024 and 2035
Figure 67: Global Peptide Therapeutics Market Value (US$ Mn), by Hybrid, 2020-2035
Figure 68: Global Peptide Therapeutics Market Value Share Analysis, by Hybrid, 2024 and 2035
Figure 69: Global Peptide Therapeutics Market Value Share Analysis, Manufacturing Type, 2024 and 2035
Figure 70: Global Peptide Therapeutics Market Value Share Analysis, Manufacturing Type, 2024
Figure 71: Global Peptide Therapeutics Market Value Share Analysis, Manufacturing Type, 2035
Figure 72: Global Peptide Therapeutics Market Attractiveness Analysis, Manufacturing Type, 2025-2035
Figure 73: Global Peptide Therapeutics Market Value (US$ Mn), by In-house, 2020-2035
Figure 74: Global Peptide Therapeutics Market Value Share Analysis, by In-house, 2024 and 2035
Figure 75: Global Peptide Therapeutics Market Value (US$ Mn), by CMO, 2020-2035
Figure 76: Global Peptide Therapeutics Market Value Share Analysis, by CMO, 2024 and 2035
Figure 77: Global Peptide Therapeutics Market Value Share Analysis, by Region, 2024 and 2035
Figure 78: Global Peptide Therapeutics Market Attractiveness Analysis, by Region, 2025-2035
Figure 79: North America Peptide Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2035
Figure 80: North America Peptide Therapeutics Market Value Share Analysis, by Country, 2024 and 2035
Figure 81: North America Peptide Therapeutics Market Attractiveness Analysis, by Country, 2025-2035
Figure 82: North America Peptide Therapeutics Market Value Share Analysis, by Application, 2024 and 2035
Figure 83: North America Peptide Therapeutics Market Attractiveness Analysis, by Application, 2025-2035
Figure 84: North America Peptide Therapeutics Market Value Share Analysis, by Route of Administration, 2024 and 2035
Figure 85: North America Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration, 2025-2035
Figure 86: North America Peptide Therapeutics Market Value Share Analysis, by Product Type, 2024 and 2035
Figure 87: North America Peptide Therapeutics Market Attractiveness Analysis, by Product Type, 2025-2035
Figure 88: North America Peptide Therapeutics Market Value Share Analysis, by Types of Peptide, 2024 and 2035
Figure 89: North America Peptide Therapeutics Market Attractiveness Analysis, by Types of Peptide, 2025-2035
Figure 90: North America Peptide Therapeutics Market Value Share Analysis, by Technology, 2024 and 2035
Figure 91: North America Peptide Therapeutics Market Attractiveness Analysis, by Technology, 2025-2035
Figure 92: North America Peptide Therapeutics Market Value Share Analysis, by Manufacturing Type, 2024 and 2035
Figure 93: North America Peptide Therapeutics Market Attractiveness Analysis, by Manufacturing Type, 2025-2035
Figure 94: Europe Peptide Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2035
Figure 95: Europe Peptide Therapeutics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 96: Europe Peptide Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 97: Europe Peptide Therapeutics Market Value Share Analysis, by Application, 2024 and 2035
Figure 98: Europe Peptide Therapeutics Market Attractiveness Analysis, by Application, 2025-2035
Figure 99: Europe Peptide Therapeutics Market Value Share Analysis, by Route of Administration, 2024 and 2035
Figure 100: Europe Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration, 2025-2035